Price $140.97 |
Market Cap
387.21B
|
Sector Health Care |
Div. Growth
5.60%
|
|
P/E
23.2
|
P/B
6.39
|
P/S
4.74
|
Dividend %
2.70%
|
|
P/CF
497.4
|
P/FCF
40.9
|
Op. Cash Flow
23.23M
|
FCF
3.6
|
|
Op. Margin
23.50%
|
Net Margin
20.70%
|
ROE
28.60%
|
ROI
17.30%
|
|
ROA
11.00%
|
EPS Growth
18.60%
|
Current Ratio
1.3
|
Debt/Equity
44.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Akorn, Inc. (AKRX) | $0.09 | - | - | 24.5M | Strong Buy |
| Reflect Scientific Inc (RSCF) | $0.06 | - | - | 4.2M | Strong Buy |
| Vycor Medical Inc (VYCO) | $0.14 | - | - | 1.3M | Strong Buy |
| Pacific Biosciences of Califor (PACB) | $3.74 | - | - | 546.9M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.24 | - | - | 50M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
